Company
United StatesPublic company, NASDAQ: INOINOVIO PHARMACEUTICALS INC (NASDAQ: INO), Plymouth Meeting, PA – FDA Inspections
Inspection records and compliance data for INOVIO PHARMACEUTICALS INC in Plymouth Meeting, Pennsylvania. 2 FDA inspections on record, last inspected June 25, 2026. Publicly traded as NASDAQ: INO.
Company Profile
This profile covers INOVIO PHARMACEUTICALS INC based in Plymouth Meeting, Pennsylvania, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected July 1, 2025. Last inspected June 25, 2026.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| June 25, 2026 | NAI | · Blood and Blood Products | 1325520 |
| July 1, 2025 | Not classified | Biologics | 1274907 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Temple University Hospital Bone Marrow Transplant Program
Biomat USA, Inc.
Vitalant Reference and Transfusion Service
UPMC Pinnacle Lancaster
Steel City Spine, Inc
Medical Home Health Options dba The Plasma Source
Central Pennsylvania Blood Bank
Sanofi
Health Network Laboratories-Pocono
Biological Specialty Corporation
Company Information
Name
INOVIO PHARMACEUTICALS INC
Stock ticker
INO
Exchange
NASDAQ
Share price
$1.46
Market cap
$150.4M
Price as of
November 6, 2026
FEI Number
3013679640
Address
Plymouth Meeting, Pennsylvania 19462, United States
Country
United States
ID: 03ac0736-e1d1-4cb5-830b-af12fc9ee289